Index Entries

1567 Results
TitleIS Publication Date
OpenVAERS
Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesFebruary 11, 2021
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled TrialJune 6, 2022
Orchestration of a CrisisOctober 29, 2022
Our World in Data
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021August 6, 2021
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical TrialsFebruary 26, 2021
Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patientsOctober 30, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-upDecember 24, 2022
Overseas Refugee Health GuidancePage last reviewed March 16, 2021
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin CApril 29, 2022
Package insert for Comirnaty and Pfizer-BioNTech COVID-19 VaccineRevised September 2023
Package insert for Moderna Spikevax COVID-19 VaccineRevised April 2024
PaedVacCOVID - safety of the BNT162b2 vaccine against the SARS-CoV-2 in children with and without comorbidities aged 5 to 11 yearsNovember 11, 2024
Panel of doctors in Nashville, TennesseeJanuary 2022
Passive inhaled mRNA vaccination for SARS-Cov-2November 24, 2020
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysisFebruary 16, 2023
Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunityApril 9, 2020
Pathology Deterioration in a Pure β-zero Thalassemia Heterozygote After mRNA COVID-19 Vaccination: A Case Report and Literature ReviewSeptember 6, 2024
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) InfectionDecember 17, 2020
Patient Betrayal: The Corruption of Healthcare, Informed Consent and the Physician-Patient RelationshipMarch 1, 2022
People's COVID-19 Vaccine Inquiry: Witness statement of Dr. Elizabeth Evans, on behalf of the UK Medical Freedom AllianceApril 10, 2024
Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States PopulationFebruary 16, 2024
Periodic Safety Update Report #3 (Pfizer)
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humansSeptember 27, 2021
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like SymptomsMarch 24, 2024
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-InfectionJanuary 10, 2022
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19November 29, 2024
Persistent Nonviral Plasmid Vector in Nasal Tissues Causes False-Positive SARS-CoV-2 Diagnostic Nucleic Acid TestsOctober 13, 2022
Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesionAugust 25, 2022
Perspective: Universal Masking in Hospitals in the Covid-19 EraMay 21, 2020
Pfizer 16+ DocumentsNovember 17, 2021 - November 1, 2023
Pfizer clinical trial: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness StudyFirst posted April 19, 2021; last updated June 27, 2023
Pfizer Corporate Rap SheetLast updated February 3, 2017
Pfizer director admits vaccine was never tested on preventing transmissionOctober 11, 2022
Pfizer DNA Detected in Colon Cancer Biopsy: Kevin McKernan Presents FindingsOctober 19, 2024
Pfizer trial paper: Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineDecember 10, 2020
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical TestingWinter 2024
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccinesNovember 6, 2024
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZenecaupdated April 7, 2023
Physicians Declaration – Global COVID Summit, Rome, ItalySeptember 2021
Physicians Declaration IIOctober 29, 2021
Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 eraNovember 20, 2021
Plaintiffs Motion for Preliminary Injunction: America’s Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the US Department of Health and Human ServicesJuly 19, 2021
Plan B Public Health Infrastructure and Operations Oversight Reform for AmericaJanuary 5, 2021
Plastic waste release caused by COVID-19 and its fate in the global oceanNovember 8, 2021
Pneumonia and Influenza Mortality Surveillance from the National Center for Health Statistics Mortality Surveillance System
Population - With a Disability, 16 Years and overAugust 4, 2023
Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report StudiesDecember 14, 2021
Position Paper – COVID-19 Vaccine for ChildrenNovember 24, 2021